Trial intelligence / Profile preview

Minocycline vs Minocycline + Azelaic Acid in Rosacea

NCT05014906Phase 4Completed

Sponsor
Dermatology Specialists Research
Start
May 2010
Primary completion
Sep 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of Azelaic acid in rosacea (2 arms), sponsored by Dermatology Specialists Research. Primary endpoint: Reduction in total lesion count at 12 weeks. Started May 2010; status: completed.

02

Drugs

Azelaic acid
03

Conditions

rosacea

Beyond the preview

Go deeper on NCT05014906.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05014906.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call